PharmaCyte Biotech Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
/ 
Frequently asked questions
To buy PharmaCyte Biotech Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PharmaCyte Biotech Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PharmaCyte Biotech Inc. is PMCB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PharmaCyte Biotech Inc. has its primary listing on NASDAQ (Small cap). You can trade PharmaCyte Biotech Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PharmaCyte Biotech Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PharmaCyte Biotech Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PharmaCyte Biotech Inc..